Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer von HALABI, Susan, LIN, Chen-Yen, KELLY, W. Kevin, FIZAZI, Karim S, MOUL, Judd W, KAPLAN, Ellen B, MORRIS, Michael J, SMALL, Eric J

Volltext

Cellular rewiring in lethal prostate cancer: the architect of drug resistance von Carceles-Cordon, Marc, Kelly, W. Kevin, Gomella, Leonard, Knudsen, Karen E., Rodriguez-Bravo, Veronica, Domingo-Domenech, Josep

Volltext

Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import von Rodriguez-Bravo, Veronica, Pippa, Raffaella, Song, Won-Min, Carceles-Cordon, Marc, Dominguez-Andres, Ana, Fujiwara, Naoto, Woo, Jungreem, Koh, Anna P., Ertel, Adam, Lokareddy, Ravi K., Cuesta-Dominguez, Alvaro, Kim, Rosa S., Rodriguez-Fernandez, Irene, Li, Peiyao, Gordon, Ronald, Hirschfield, Hadassa, Prats, Josep M., Reddy, E. Premkumar, Fatatis, Alessandro, Petrylak, Daniel P., Gomella, Leonard, Kelly, W. Kevin, Lowe, Scott W., Knudsen, Karen E., Galsky, Matthew D., Cingolani, Gino, Lujambio, Amaia, Hoshida, Yujin, Domingo-Domenech, Josep

Volltext

An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer von LIU, Glenn, KELLY, W. Kevin, WILDING, George, LEOPOLD, Lance, BRILL, Kimberli, SOMER, Bradley

Volltext

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy von Den, Robert B., MD, Feng, Felix Y., MD, Showalter, Timothy N., MD, Mishra, Mark V., MD, Trabulsi, Edouard J., MD, Lallas, Costas D., MD, Gomella, Leonard G., MD, Kelly, W. Kevin, DO, Birbe, Ruth C., MD, McCue, Peter A., MD, Ghadessi, Mercedeh, MSc, Yousefi, Kasra, MSc, Davicioni, Elai, PhD, Knudsen, Karen E., PhD, Dicker, Adam P., MD, PhD

Volltext

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy von Marascio, Joseph, Spratt, Daniel E., Zhang, Jingbin, Trabulsi, Edouard J., Le, Tiffany, Sedzorme, Worlanyo Sosu, Beeler, Whitney H., Davicioni, Elai, Dabbas, Bashar, Lin, Daniel W., Gore, John L., Bloom, Matthew, Mann, Mark, Mark, J. Ryan, Calvaresi, Anne, Godwin, James L., McCue, Peter, Hurwitz, Mark D., Kelly, W. Kevin, Lallas, Costas D., Knudsen, Karen E., Gomella, Leonard G., Dicker, Adam P., Den, Robert B.

Volltext

Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration von SMALETZ, Oren, SCHER, Howard I, SMALL, Eric J, VERBEL, David A, MCMILLAN, Alex, REGAN, Kevin, KELLY, W. Kevin, KATTAN, Michael W

Volltext

Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate... von Silberstein, Jonathan L., Poon, Stephen A., Sjoberg, Daniel D., Maschino, Alexandra C., Vickers, Andrew J., Bernie, Aaron, Konety, Badrinath R., Kevin Kelly, W., Eastham, James A.

Volltext

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer von GALSKY, Matthew D, EISENBERGER, Mario, MOORE-COOPER, Sandra, KELLY, W. Kevin, SLOVIN, Susan F, DELACRUZ, Anthony, LEE, Yih, WEBB, Iain J, SCHER, Howard I

Volltext

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer von SOLIT, David B, IVY, S. Percy, LARSON, Steven, SCHWARTZ, Lawrence, EGORIN, Merrill J, ROSEN, Neal, SCHER, Howard I, KOPIL, Catherine, SIKORSKI, Rachel, MORRIS, Michael J, SLOVIN, Susan F, KELLY, W. Kevin, DELACRUZ, Anthony, CURLEY, Tracy, HELLER, Glenn

Volltext

Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer von Martin, Darryl T., PhD, Hoimes, Christopher J., DO, Kaimakliotis, Hristos Z., MD, Cheng, Christopher J., PhD, Zhang, Ke, PhD, Liu, Jingchun, MD, PhD, Wheeler, Marcia A., MS, Kelly, W. Kevin, DO, Tew, Greg N., PhD, Saltzman, W. Mark, PhD, Weiss, Robert M., MD

Volltext

Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metas... von GALSKY, Matthew D, SMALL, Eric J, KELLY, W. Kevin, OH, William K, CHEN, Isan, SMITH, David C, COLEVAS, A. Dimitrios, MARTONE, Lou, CURLEY, Tracy, DELACRUZ, Anthony, SCHER, Howard I

Volltext

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data von Fizazi, Karim, Dr, Le Maitre, Aurelie, MSc, Hudes, Gary, MD, Berry, William R, MD, Kelly, W Kevin, MD, Eymard, Jean-Christophe, MD, Logothetis, Christopher J, MD, Pignon, Jean-Pierre, MD, Michiels, Stefan, MSc

Volltext

Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After Radical Prostatectomy von ZOHARA, DOTAN, HRICAK, Hedvig, SCARDINO, Peter T, KATTAN, Michael W, BIANCO, Fernando J, RABBANI, Farhang, EASTHAM, James A, FEARN, Paul, SCHER, Howard I, KELLY, Kevin W, CHEN, Hui-Ni, SCHÖDER, Heiko

Volltext

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance) von SMITH, Matthew R, HALABI, Susan, SAAD, Fred, SANFORD, Ben, KELLY, W. Kevin, MORRIS, Michael, SMALL, Eric J, RYAN, Charles J, HUSSAIN, Arif, VOGELZANG, Nicholas, STADLER, Walter, HAUKE, Ralph J, MONK, J. Paul, SAYLOR, Philip, BHOOPALAM, Nirmala

Volltext

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy von Morris, Michael J, Akhurst, Timothy, Larson, Steven M, Ditullio, Marisa, Chu, Elaina, Siedlecki, Karen, Verbel, David, Heller, Glenn, Kelly, W Kevin, Slovin, Susan, Schwartz, Lawrence, Scher, Howard I

Volltext

Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer von MORRIS, Michael J, DIVGI, Chaitanya R, SOLIT, David, HALPERN, Jennifer, DELACRUZ, Anthony, CURLEY, Tracy, FINN, Ronald, O'DONOGHUE, Joseph A, LIVINGSTON, Philip, LARSON, Steven, SCHER, Howard I, PANDIT-TASKAR, Neeta, BATRAKI, Maria, WARREN, Nyasha, NACCA, Angelo, SMITH-JONES, Peter, SCHWARTZ, Lawrence, KELLY, W. Kevin, SLOVIN, Susan

Volltext

Redefining hormone resistance in prostate cancer von Hoimes, Christopher J., Kelly, W. Kevin

Volltext

Evaluating the Impact of a Novel Program to Address Acute Food Insecurity Among Cancer Patients von Sina, Elliott M, Rowe, Michael, Mancuso, Gina, Garber, Gregory, Kelly, W Kevin, Leader, Amy E

Volltext

Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data von Gomaa, Sameh, Kelly, W. Kevin, Mitchell, Edith, Storozynsky, Eugene, Zeigler-Johnson, Charnita, Juon, Hee-Soon, Wen, Kuang-Yi

Volltext